NO934655L - Legemiddel for gram-positive sykdommer i akvatiske arter - Google Patents

Legemiddel for gram-positive sykdommer i akvatiske arter

Info

Publication number
NO934655L
NO934655L NO934655A NO934655A NO934655L NO 934655 L NO934655 L NO 934655L NO 934655 A NO934655 A NO 934655A NO 934655 A NO934655 A NO 934655A NO 934655 L NO934655 L NO 934655L
Authority
NO
Norway
Prior art keywords
gram
drug
aquatic species
positive diseases
positive
Prior art date
Application number
NO934655A
Other languages
English (en)
Inventor
Earl Eugene Ose
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO934655L publication Critical patent/NO934655L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelse av tilmlcosln og andre forbindelser Ifølge US-PS 4.820.695 for behandling av gram-posltlve bakterielle patogener l akvatiske arter er beskrevet.
NO934655A 1992-12-21 1993-12-16 Legemiddel for gram-positive sykdommer i akvatiske arter NO934655L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99457992A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
NO934655L true NO934655L (no) 1994-06-22

Family

ID=25540817

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934655A NO934655L (no) 1992-12-21 1993-12-16 Legemiddel for gram-positive sykdommer i akvatiske arter
NO934655D NO934655D0 (no) 1992-12-21 1993-12-16 Legemiddel for gram-positive sykdommer i akvatiske arter

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO934655D NO934655D0 (no) 1992-12-21 1993-12-16 Legemiddel for gram-positive sykdommer i akvatiske arter

Country Status (12)

Country Link
EP (1) EP0606747A1 (no)
JP (1) JPH06217708A (no)
KR (1) KR940013500A (no)
CN (1) CN1093371A (no)
AU (1) AU5252793A (no)
CA (1) CA2111635A1 (no)
CZ (1) CZ276893A3 (no)
HU (1) HUT66447A (no)
IL (1) IL108047A0 (no)
NO (2) NO934655L (no)
NZ (1) NZ250465A (no)
ZA (1) ZA939428B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
US6518252B2 (en) * 2000-09-20 2003-02-11 University Of Georgia Research Foundation, Inc. Method of treating aquatic animals with an antimicrobial agent and chelating agent
EP1446103B1 (en) * 2001-10-19 2015-12-23 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
PT2782922T (pt) 2011-11-25 2018-02-05 The Kitasato Inst Derivados antibacterianos de tilosina e processos para a sua preparação
AU2014270353B2 (en) 2013-05-23 2018-09-20 Elanco Animal Health Gmbh Tylosin derivatives and method for preparation thereof
CN105456184B (zh) * 2015-12-11 2019-04-16 天津市中升挑战生物科技有限公司 一种替米考星注射液及其制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics

Also Published As

Publication number Publication date
CN1093371A (zh) 1994-10-12
HUT66447A (en) 1994-11-28
KR940013500A (ko) 1994-07-15
NO934655D0 (no) 1993-12-16
IL108047A0 (en) 1994-04-12
NZ250465A (en) 1995-10-26
EP0606747A1 (en) 1994-07-20
ZA939428B (en) 1995-06-15
CA2111635A1 (en) 1994-06-22
CZ276893A3 (en) 1994-07-13
AU5252793A (en) 1994-06-30
JPH06217708A (ja) 1994-08-09

Similar Documents

Publication Publication Date Title
KR0145958B1 (en) Antibacterial agents
ES8502687A1 (es) Procedimiento para preparar derivados de 4-oxo-1,4-dihidroquinoleina.
DK198791D0 (da) Terapeutiske kombinationer af 3'-azido-3'-desoxythymidin og andre terapeutiske midler
ATE224374T1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
MY101842A (en) Treatment of oral diseases.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
NO934655L (no) Legemiddel for gram-positive sykdommer i akvatiske arter
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
ES459086A1 (es) Procedimiento de obtencion de nuevas aril (trifluoretil) a- minas.
SE9002731D0 (sv) Product comprising growth factor
FR2656528B1 (fr) Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement.
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
ZA922102B (en) Method of treatment
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
ATE203160T1 (de) Tierärztliche behandlung
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ES2038702T3 (es) Un procedimiento para preparar derivados triazolopirimidina triciclicos.
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
DE59008759D1 (de) Verwendung von interleukin-2 zur behandlung der endotoxinämie.